Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
105.00
-0.80 (-0.76%)
At close: Dec 4, 2025
Beacon Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 24,255 | 35,528 | 56,595 | 59,667 | 28,552 | 14,022 | Upgrade
|
| Market Cap Growth | -11.09% | -37.22% | -5.15% | 108.98% | 103.62% | 201.99% | Upgrade
|
| Enterprise Value | 30,760 | 45,350 | 62,791 | 63,025 | 30,523 | 15,593 | Upgrade
|
| Last Close Price | 105.00 | 148.05 | 234.30 | 245.53 | 116.74 | 56.84 | Upgrade
|
| PE Ratio | 42.55 | 68.19 | 111.01 | 63.81 | 33.08 | 36.83 | Upgrade
|
| PS Ratio | 2.09 | 3.32 | 6.65 | 7.44 | 4.01 | 2.51 | Upgrade
|
| PB Ratio | 3.72 | 5.83 | 9.53 | 10.04 | 5.33 | 3.03 | Upgrade
|
| P/TBV Ratio | 3.73 | 5.86 | 9.54 | 10.04 | 5.33 | 3.03 | Upgrade
|
| P/FCF Ratio | 16.00 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 13.22 | - | 91.11 | 55.14 | 145.26 | 48.16 | Upgrade
|
| EV/Sales Ratio | 2.66 | 4.24 | 7.38 | 7.86 | 4.29 | 2.79 | Upgrade
|
| EV/EBITDA Ratio | 11.29 | 19.25 | 41.92 | 30.64 | 17.47 | 18.46 | Upgrade
|
| EV/EBIT Ratio | 14.04 | 24.80 | 64.13 | 38.97 | 22.42 | 46.76 | Upgrade
|
| EV/FCF Ratio | 20.30 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 1.54 | 1.69 | 1.25 | 0.64 | 0.47 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | 3.70 | 4.38 | 4.98 | 1.86 | 1.43 | 2.58 | Upgrade
|
| Debt / FCF Ratio | 6.64 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.62 | 0.64 | 0.67 | 0.83 | 0.91 | 0.93 | Upgrade
|
| Inventory Turnover | 2.07 | 2.14 | 2.15 | 2.40 | 2.99 | 2.68 | Upgrade
|
| Quick Ratio | 0.68 | 0.36 | 0.36 | 0.54 | 0.82 | 0.90 | Upgrade
|
| Current Ratio | 1.42 | 1.37 | 1.20 | 1.38 | 1.87 | 1.84 | Upgrade
|
| Return on Equity (ROE) | 8.88% | 8.66% | 8.58% | 16.55% | 17.29% | 10.01% | Upgrade
|
| Return on Assets (ROA) | 7.28% | 6.81% | 4.81% | 10.45% | 10.83% | 3.46% | Upgrade
|
| Return on Capital (ROIC) | 8.42% | 7.67% | 5.28% | 11.47% | 11.61% | 3.60% | Upgrade
|
| Return on Capital Employed (ROCE) | 21.50% | 18.90% | 13.70% | 26.30% | 23.70% | 6.50% | Upgrade
|
| Earnings Yield | 2.35% | 1.47% | 0.90% | 1.57% | 3.02% | 2.71% | Upgrade
|
| FCF Yield | 6.25% | -3.59% | -2.11% | -1.07% | -0.41% | -0.16% | Upgrade
|
| Dividend Yield | 2.00% | 1.35% | 0.68% | 0.65% | 1.29% | - | Upgrade
|
| Payout Ratio | 129.69% | 70.93% | 72.78% | 39.95% | 6.88% | 15.23% | Upgrade
|
| Total Shareholder Return | 2.00% | 1.35% | 0.68% | 0.65% | 1.29% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.